The role of PCT in monitoring the antibiotherapy in septic surgical patient;Rolul PCT în monitorizarea antibioterapiei la bolnavul septic chirurgical

Chirurgia (Romania)

Volumn 109, Issue 1, 2012, Pages 71-78

  Pundiche, M ^a,b   Sarbu V ^a,b   Unc, O D ^a,b   Grasa, C ^a,b   Martinescu, A ^a   Badarau V ^b   Durbala I ^a,b   Sapte E ^a   Pasare R ^a,b   Voineagu, L ^a,b   Iordache, I ^b   Vanca A ^b   Adam, A ^a  

^a OVIDIUS UNIVERSITY   (Romania)

^b Spitalul Clinic Judetean de Urgenta Cluj   (Romania)

Author keywords

Antibiotics; Immunomodulation; Procalcitonina; Severe sepsis; SIRS

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOOD; COMPARATIVE STUDY; CRITICAL ILLNESS; EARLY DIAGNOSIS; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MONITORING; MORTALITY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; CRITICAL ILLNESS; EARLY DIAGNOSIS; HUMANS; LENGTH OF STAY; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84874355003     PISSN: 12219118     EISSN: 1842368X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 1997; 112(1): 235-43.
2. Siloşi C, Ghelase F, Siloşi I, Ghelase SM, Rogoz S, Cioarǎ F, et al. The evaluation of immunoinflammatory response in acute bacterial peritonitis Chirurgia (Bucur). 2010; 105(6): 789-96. [Article in Romanian]
3. Israil AM, Delcaru C, Palade RS, Chifiriuc C, Iordache C, Vasile D, et al. Bacteriological aspects implicated in abdominal surgical emergencies. Chirurgia (Bucur). 2010; 105(6): 779-87.
4. McLean AS, et al. Yearbook of Intensive Care 2007.
5. Marinescu SM. Noii biomarkeri. Valoarea diagnosticǎ şi prognosticǎ la pacienţii critici. Actualitaţi în anestezie, terapie intensivǎ şi medicina de urgenţǎ. 2007, p. 269.
6. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008; 177(5): 498-505. Epub 2007 Dec 20.
7. Laborator Synevo. Referintele specifice tehnologiei de lucru utilizate 2010. Ref Type: Catalog.
8. Lothar T. Inflammation. Procalcitonin (PCT). In: Clinical Laboratory Diagnostics. 1998. p. 710-713.
9. Brunkhorst FM, Wegscheider K, Forycki Z F, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med. 2000 Mar; 26 Suppl 2:S148-52.
10. www.mayomedicallaboratories.com. Test catalog. Procalcitonin, Serum.
11. Schuetz P, Christ-Crain Mirjam, Müller B. Procalcitonin for disease severity assessment and guidance of treatment. Advances in sepsis. 2008.
12. Schuetz P, Christ-Crain M, Müller B. Biomarkers to improve diagnostic and prognostic accuracy in systemic infections. Curr Opin Crit Care. 2007; 13(5): 578-85.
13. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007; 7(3): 210-7.
14. Carlet J. Rapid diagnostic methods in the detection of sepsis. Infect Dis Clin North Am. 1999; 13(2): 483-94, xi.
15. Briel M, Christ-Crain M, Young J, Schuetz P, Huber P, Périat P, et al. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]. BMC Fam Pract. 2005; 6: 34.
16. Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R, et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest. 2007; 131(4): 1058-67.
17. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006; 34(10): 2596-602.
18. Becker KL, Snider R, Nylen ES, Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008 Mar; 36(3): 941-52.
19. Muller B, et al. Eur J of Clin Investigation 2007; 37.
20. Nylen E, Muller B, Becker KL, Snider R. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis. 2003; 36(6): 823-4; author reply 826-7.
21. Comment on Clin Infect Dis. 2002; 35(2): 156-61.
22. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G Y. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med. 2006; 34(7): 1996-2003.
23. Dellinger R P, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36(1): 296-327.
24. Erratum in Crit Care Med. 2008; 36(4): 1394-6.
25. Steven Tallia and Jolanta E. Kunicka, PhD/-Sepsis: Improving the odds. Perspectives · Spring 2009 www.siemens.com/diagnostics.
26. Jensen JU, Heslet L, Jensen Th, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34(10): 2596-602
27. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinde intervention trial. Lancet. 2004; 363: 600-7.
28. Westphal M, et al. Eur Resp J 2004; 24.
29. Christ - Crain M et al. Yearbook of Intensive Care 2007.
30. Assicot M, Gendrel D, Garsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993; 341(8844): 515-8.
31. Levy MM, Fink M P, Marshall JC, Abraham, Angus D, Cook D, et al. 2001/SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31(4): 1250-6.
32. Bone RC, Balk RA, Cerra FB, Dellinger R P, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6): 1644-55.
33. Steinbach G, Rau B, Debard AL, Javourez J F, Bienvenu J, Ponzio A, et al. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin Chem Lab Med. 2004; 42(4): 440-9.